Aptinyx Reports First Quarter 2019 Financial Results and Provides Corporate Update

    NEXT STORY
    Precision BioSciences Appoints Christopher R. Heery, M.D., as Chief Medical Officer
    PREV STORY
    Achillion Granted Twentieth Patent for Factor D Portfolio
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Inventiva to host a Key Opinion Leader webcast from the AASLD The Liver Meeting Digital Experience™ 2020

    author_avatar
    NASDAQ Market News

    Sorrento Releases Positive Results of Phase 1B Trial of Resiniferatoxin (RTX) In Reduction of OsteoArthritis (OA) Knee Pain

    author_avatar
    NASDAQ Market News

    Spero Therapeutics to Present Data for All Pipeline Programs at the ASM Microbe 2019 Conference

    author_avatar
    NASDAQ Market News